A Phase 1, Open-Label, Single Ascending Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of ES-481 After Oral Administration in Healthy Volunteers
Fields of Study & Subjects
Statistical Methods in Clinical Trials
Chemotherapy-induced organ toxicity mitigation
Safe Handling of Antineoplastic Drugs
Publication details
- Journal / source
- European Journal of Drug Metabolism and Pharmacokinetics
- Publisher
- Springer Science and Business Media LLC
- Volume
- 51
- Issue
- 1
- Pages
- 97–109
- Publication date
- 1 January 2026
- Language
- EN